Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1) (N-Term) Peptide
-
- Target See all NOXA (PMAIP1) products
- NOXA (PMAIP1) (Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
17 amino acids near the amino terminus of human Noxa.
Human
-
-
- Application Notes
- Noxa peptide is used for blocking the activity of Noxa.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- NOXA (PMAIP1) (Phorbol-12-Myristate-13-Acetate-Induced Protein 1 (PMAIP1))
- Synonyms
- TN3 Peptide, PMAIP1 Peptide, zgc:162379 Peptide, APR Peptide, NOXA Peptide, Noxa Peptide, phorbol-12-myristate-13-acetate-induced protein 1 Peptide, PMAIP1 Peptide, pmaip1 Peptide, Pmaip1 Peptide
-